The Pharmaletter
One To Watch
Brancaster Pharma
Brancaster is a specialty pharmaceutical company focused on innovative therapies for patients who suffer from rare conditions.
The company's first product launched in the UK was Bramox (midodrine), the first medicine to be licensed in the UK to treat severe orthostatic hypotension due to autonomic dysfunction.
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze